ZebraSci

Mission: Enable biotechnology and pharmaceutical companies to accelerate combination product development and deliver therapies to patients ZebraSci is a contract research and development organization with a focus on parenteral combination products. We have helped our clients commercialize over 30 combination products in multiple geographies over the last decade. We pride ourselves in our craft and develop specific protocols for each client project. We support our clients with consultative support in early feasibility testing through product verification/validation. Once products are commercialized, we often continue to support incoming inspection, final product lot release testing, and market complaint root cause investigations. ZebraSci has...

Non-destructive lubrication characterization; stability and aging studies; iso 11040 testing; container closure integrity; combination product development; iso 11608 testing; product complaint investigations; root cause investigation; packaging testing; shipping studies; small batch filling; small batch device assembly; designs of experiments; primary packaging qualification; metrology and measurement ; design verification testing; method development and qualification; custom primary packaging lubrication; clean room; iso 7886 testing; prefilled syringes; pharmaceutical packaging; self administration devices; autoinjectors; pen injectors; combination products; pharmaceuticals; drug delivery; parenteral drug delivery; primary containers; primary packaging; syringes; needles; iso 17025; and astm d1469

Zebrasci operates in the Biotechnology research industry.

Zebrasci's HQ phone number is 18002274121

Zebrasci's revenue is 11m - 100m

Zebrasci has 11 - 50 employees.